Where Would The Injectable Seizure Drugs Market Stand In The Next Decade?

Posted by Steve Sharma on May 14th, 2021

Injectable seizure drugs are important in treating emergencies of clinical seizure emergencies and in other treatments where oral administration is not possible. The injectable seizure drugs provide rapid and complete delivery (through blood vessels) or almost complete (muscle gain) bioavailability. Controlled administration of the injectable seizure drugs is feasible with intravenous but not intramuscular formulations. The median incidence of acute symptomatic seizures is 29–39 per 100,000 per year. Epilepsy affects nearly 3 million people in the US, with nearly 500 new cases of epilepsy diagnosed every day.

Seizures, a major symptom of epilepsy, are defined as abnormal paroxysmal electrical disturbances of cortical neural networks, many anti-epileptic drugs work in some ways that reduce neuronal excitability.

With the increasing number of epileptic seizures due to greater exposure to perinatal risk factors and higher rates of CNS disease, the injectable seizure market is the leading choice of dosage form for seizure treatment.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32417